Rudolf Kaaks

101.4k citations

308 papers · 18.2k indexed · 4 hit papers · h-index 70

Impact in

Oncology top 0.2%
- Cancer Risks and Factors
Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism

Papers in

Oncology 112
- Cancer Risks and Factors 83
Endocrinology, Diabetes and Metabolism 57
- Growth Hormone and Insulin-like Growth Factors 41

Co-authors: Eugenia E. Calle Annekatrin Lukanova Elio Ríboli Harri Vainio Franca Bianchini Sabina Rinaldi Mindy S. Kurzer Pär Stattin
Journals: International Journal of Cancer (38 papers)Cancer Causes & Control (15 papers)Cancer Epidemiology Biomarkers & Prevention (14 papers)International Journal of Epidemiology (11 papers)Nutrients (10 papers)
Partner nations: Germany France United States

In The Last Decade

Rudolf Kaaks

299 papers receiving 17.7k citations

Hit Papers

align trajectories log scale

Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial 2019 · 292 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 International Journal of Cancer
2004 Nature reviews. Cancer
2002 The Lancet Oncology
2002 PubMed

Peers

Countries citing papers authored by Rudolf Kaaks

Since Specialization

Citations

This map shows the geographic impact of Rudolf Kaaks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Kaaks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Kaaks more than expected).

Fields of papers citing papers by Rudolf Kaaks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Kaaks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Kaaks. The network helps show where Rudolf Kaaks may publish in the future.

Co-authors

The 25 scholars most cited alongside Rudolf Kaaks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rudolf Kaaks Line = papers co-authored together Rudolf Kaaks links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer – Baseline Findings for CA125 Clinical Cancer Research ·Rudolf Kaaks, Victoria Cooley, Trasias Mukama, Lauren R. Teras, Alpa V. Patel, Giovanna Masala, Marta Crous‐Bou, Holly R. Harris, Hilde Langseth, Heljä‐Marja Surcel, Nicolas Wentzensen, Kathryn L. Terry, Naoko Sasamoto, Shelley S. Tworoger, Renée T. Fortner	2025	0
2	Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer International Journal of Cancer ·Victoria Cooley, Renée T. Fortner, Trasias Mukama, Sabine Naudin, Valeria Pala, Laure Dossus, Inger Torhild Gram, Karina Standahl Olsen, María‐José Sánchez, Pernilla Israelsson, Naomi E. Allen, Hilde Langseth, Rudolf Kaaks	2025	0
3	Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI) Scientific Reports ·Francisco O. Cortés-Ibáñez, Theron Johnson, Mario Mascalchi, Verena Katzke, Stefan Delorme, Rudolf Kaaks	2024	2
4	Positionspapier zur Implementierung eines nationalen organisierten Programms in Deutschland zur Früherkennung von Lungenkrebs in Risikopopulationen mittels Low-dose-CT-Screening inklusive Management von abklärungsbedürftigen Screeningbefunden RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Jens Vogel‐Claussen, Torsten Blum, Stefan Andreas, Torsten T. Bauer, Jörg Barkhausen, Volker Harth, Hans‐Ulrich Kauczor, Wulf Pankow, K Welcker, Rudolf Kaaks, Hans Hoffmann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2023	2
5	Association of circulating free and total oxysterols in breast cancer patients Clinical Chemistry and Laboratory Medicine (CCLM) ·Nina Sophia Decker, Theron Johnson, Sabine Behrens, Nadia Obi, Rudolf Kaaks, Jenny Chang‐Claude, Renée T. Fortner	2022	5
6	Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS) International Journal of Molecular Sciences ·Christian Faltus, Angelika Lahnsteiner, Myrto Barrdahl, Yassen Assenov, Anika Hüsing, Olga Bogatyrova, Marina Laplana, Theron Johnson, Thomas Muley, Michael Meister, Arne Warth, Michael Thomas, Christoph Plass, Rudolf Kaaks, Angela Risch	2022	3
7	Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening Cancer Prevention Research ·Anne S. Quante, Anika Hüsing, Jenny Chang‐Claude, Marion Kiechle, Rudolf Kaaks, Ruth M. Pfeiffer	2021	6
8	Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges International Journal of Cancer ·Kevin ten Haaf, Carlijn M. van der Aalst, Harry J. de Koning, Rudolf Kaaks, Martin C. Tammemägi	2021	46
9	Iron status in relation to cancer risk and mortality: Findings from a population‐based prospective study International Journal of Cancer ·Daniel A. Quintana Pacheco, Disorn Sookthai, Mirja E. Graf, Ruth Schübel, Theron Johnson, Verena Katzke, Rudolf Kaaks, Tilman Kühn	2018	29
10	Pre‐diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP‐selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study International Journal of Cancer ·Mirja E. Graf, Disorn Sookthai, Theron Johnson, Ruth Schübel, Sandra González Maldonado, Laura Pletsch‐Borba, Verena Katzke, Peter Bugert, Michael Hoffmeister, Rudolf Kaaks, Tilman Kühn	2018	11
11	A Comparative Study on the WCRF International/University of Bristol Methodology for Systematic Reviews of Mechanisms Underpinning Exposure–Cancer Associations Cancer Epidemiology Biomarkers & Prevention ·Gökhan Ertaylan, Charlotte Le Cornet, Eline H. van Roekel, Audrey Jung, Martijn J.L. Bours, Antje Damms-Machado, Piet A. van den Brandt, Helena Schöck, Theo M. de Kok, Jan Theys, Ilja C.W. Arts, Rudolf Kaaks, Matty P. Weijenberg, Renée T. Fortner	2017	8
12	Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort Cancer Research ·Renée T. Fortner, Helena Schöck, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, Hans-Åke Lakso, Minna Tanner, Raija Kallio, Heikki Joensuu, Jaana Korpela, Adetunji T. Toriola, Göran Hallmans, Kjell Grankvist, Anne Zeleniuch‐Jacquotte, Paolo Toniolo, Eva Lundin, Heljä‐Marja Surcel	2016	7
13	Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort Cancer Prevention Research ·Kuanrong Li, Anika Hüsing, Disorn Sookthai, Manuela M. Bergmann, Heiner Boeing, Nikolaus Becker, Rudolf Kaaks	2015	70
14	Early Pregnancy Sex Steroids and Maternal Breast Cancer: A Nested Case–Control Study Cancer Research ·Renée T. Fortner, Helena Schöck, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, Hans‐Åke Lakso, Minna Tanner, Raija Kallio, Heikki Joensuu, Kjell Grankvist, Anne Zeleniuch‐Jacquotte, Paolo Toniolo, Eva Lundin, Heljä‐Marja Surcel	2014	14
15	Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk Cancer Research ·Kevin Brennan, Montserrat García‐Closas, Nick Orr, Olivia Fletcher, Michael E. Jones, Alan Ashworth, Anthony J. Swerdlow, Heather Thorne, Elio Ríboli, Paolo Vineis, Miren Dorronsoro, Françoise Clavel‐Chapelon, Salvatore Panico, N. Charlotte Onland‐Moret, Dimitrios Trichopoulos, Rudolf Kaaks, Kay‐Tee Khaw, Robert Brown, James M. Flanagan	2012	118
16	Association between Genetic Variants in the 8q24 Cancer Risk Regions and Circulating Levels of Androgens and Sex Hormone–Binding Globulin Cancer Epidemiology Biomarkers & Prevention ·Lisa W. Chu, Tamra E. Meyer, Qizhai Li, Idan Menashe, Kai Yu, Philip S. Rosenberg, Wen‐Yi Huang, Sabah M. Quraishi, Rudolf Kaaks, Jocelyn M. Weiss, Richard B. Hayes, Stephen J. Chanock, Ann W. Hsing	2010	10
17	Associations of Plasma C-Peptide and IGFBP-1 Levels with Risk of Colorectal Adenoma in a Multiethnic Population Cancer Epidemiology Biomarkers & Prevention ·Loı̈c Le Marchand, Hansong Wang, Sabina Rinaldi, Rudolf Kaaks, Thomas Vogt, Lance Yokochi, Robert W. Decker	2010	30
18	Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort Cancer Research ·Rudolf Kaaks, Pär Stattin, Stéphanie Villar, Anna R. Poetsch, Laure Dossus, Alexandra Nieters, Elio Ríboli, Richard Palmqvist, Göran Hallmans, Christoph Plass, Marlin D. Friesen	2009	25
19	Overweight, obesity, and cancer risk The Lancet Oncology ·Franca Bianchini, Rudolf Kaaks, Harri Vainio Hit paper breakdown →	2002	707
20	Ratios of IGF-I, IGF Binding Protein-3, and Prostate-Specific Antigen in Prostate Cancer Detection The Journal of Clinical Endocrinology & Metabolism ·Pär Stattin, Ulf‐Håkan Stenman, Elio Ríboli, Göran Hallmans, Rudolf Kaaks	2001	8

About Rudolf Kaaks

Rudolf Kaaks is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Cancer Research, Reproductive Medicine and Public Health, Environmental and Occupational Health, having authored 308 papers that have together received 18.2k indexed citations. Recurring topics across this work include Cancer Risks and Factors (83 papers), Nutritional Studies and Diet (51 papers), Metabolism, Diabetes, and Cancer (43 papers), Growth Hormone and Insulin-like Growth Factors (41 papers), Estrogen and related hormone effects (33 papers), Cancer, Lipids, and Metabolism (27 papers), Lung Cancer Diagnosis and Treatment (25 papers) and Diet and metabolism studies (19 papers). The work is most often cited by research in Oncology (6.2k citations), Cancer Research (3.2k citations), Endocrinology, Diabetes and Metabolism (2.9k citations), Obstetrics and Gynecology (1.1k citations) and Reproductive Medicine (1.1k citations). Rudolf Kaaks has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Eugenia E. Calle, Annekatrin Lukanova, Elio Ríboli, Harri Vainio, Franca Bianchini, Sabina Rinaldi, Mindy S. Kurzer, Pär Stattin, Carine Biessy and Tilman Kühn. Their work appears in journals such as International Journal of Cancer, Cancer Causes & Control, Cancer Epidemiology Biomarkers & Prevention, International Journal of Epidemiology and Nutrients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact